Shanghai Runda Medical Technology Co (603108.SS) Stock Price
Shanghai Runda Medical Technology Co Price
Over the last 14 years Shanghai Runda Medical Technology Co grew revenue by 18.7% annually, reaching 7.00 B CNY. Earnings per share have declined at 0.1% per year over the last 13 years. For Shanghai Runda Medical Technology Co, the net margin of -7.8% is down versus 4.3% a few years ago. At today's price the dividend yield works out to roughly 0.32%. The consensus 12-month price target for Shanghai Runda Medical Technology Co is 24.28 CNY, about 155.3% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Shanghai Runda Medical Technology Co stock price
Shanghai Runda Medical Technology Co business model & stock analysis
Frequently asked questions about Shanghai Runda Medical Technology Co
Analysts currently set an average price target of 24.28 CNY for the Shanghai Runda Medical Technology Co stock (median: 24.28 CNY), implying +155.3 % versus the latest price. The consensus is based on 5 analyst ratings.
Shanghai Runda Medical Technology Co Analyst Price Targets 2026
5 analysts currently rate the Shanghai Runda Medical Technology Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Shanghai Runda Medical Technology Co to generate revenue of 8.70 B CNY and earnings per share of 0.41 CNY.
Shanghai Runda Medical Technology Co Analyst Price Targets 2026
Converted at the current exchange rate, the Shanghai Runda Medical Technology Co share trades at 1.27 EUR (9.51 CNY).
The Shanghai Runda Medical Technology Co share (603108.SS) is listed on 1 stock exchanges, including: Shanghai (603108.SS).
The expected revenue of Shanghai Runda Medical Technology Co is 8.70 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Shanghai Runda Medical Technology Co is 245.69 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Shanghai Runda Medical Technology Co is currently 23.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai Runda Medical Technology Co stock.
The price-to-sales ratio (P/S) of Shanghai Runda Medical Technology Co is currently 0.66. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai Runda Medical Technology Co stock.
The Eulerpool Quality Score for Shanghai Runda Medical Technology Co is 3/10.
The ISIN of Shanghai Runda Medical Technology Co is CNE100002318. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Shanghai Runda Medical Technology Co is 603108.SS. The ticker symbol is used to trade Shanghai Runda Medical Technology Co shares on the stock exchange.
Shanghai Runda Medical Technology Co stock
Shanghai Runda Medical Technology Co Peer Group
Shanghai Runda Medical Technology Co Ticker
Shanghai Runda Medical Technology Co FIGI
All fundamentals and in-depth analysis of Shanghai Runda Medical Technology Co
Our stock analysis for Shanghai Runda Medical Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Runda Medical Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.